Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518 –2526

We were interested by the recent article from Gange et al. (1), who reported that 1.74% of 71,817 individuals with newly diagnosed type 2 diabetes had a proliferative retinopathy 5 years later. The authors mentioned that this incidence was probably underestimated because the patients were not mandated to follow-up at strict intervals, which prompted us to analyze how many of our patients with recent ( ≤5-year duration) type 2 diabetes had a sight-threatening retinopathy.
Source: Diabetes Care - Category: Endocrinology Source Type: research